Inhibition of the Binding of Variants of SARS-CoV-2 Coronavirus Spike Protein to a Human Rreceptor by Chlorine Dioxide
Norio Ogata and Takanori Miura Aim: COVID-19 caused by a new coronavirus, SARS-CoV-2, has become an ongoing worldwide pandemic. A safe and potent virucidal disinfection system is urgently needed to protect the population from the virus. Chlorine Dioxide (ClO2) is a powerful disinfectant that is known to inactivate both viruses and bacteria. The aim of […]
Strategies for the Management of Spike Protein-Related Pathology
Matthew T. J. Halma, Christof Ploth, Paul Marik and Theresa A. Lawrie In the wake of the COVID-19 crisis, a need has arisen to prevent and treat two related conditions, COVID-19 vaccine injury and long COVID-19, both of which can trace at least part of their aetiology to the spike protein, which can cause harm […]
New Peer-Reviewed Study Outlines Promising Therapies for Treating Long Covid and C-19 Vaccine Injury
World Council for Health An international team of physicians and scientists recently completed the first peer-reviewed research into the available options for treating long Covid and Covid-19 vaccine injury that will lay the groundwork for a better understanding and potential future treatments for the two conditions. … “This research shows that there is clear scientific […]
How Molecular Hydrogen Can Help Your Immune System
Joseph Mercola Molecular hydrogen (H2 gas) has powerful antioxidant and anti-in ammatory effects, making it potentially useful for COVID-19. Being the smallest molecule in the universe and having no polar charge, the hydrogen molecule is also able to diffuse through all cell membranes and subcellular compartments, including the nucleus and the mitochondria. It doesn’t need […]
Natto Extract, a Japanese Fermented Soybean Food, Directly Inhibits Viral Infections Including SARS-CoV-2 in vitro
Mami Oba et al. Natto, a traditional Japanese fermented soybean food, is well known to be nutritious and beneficial for health. In this study, we examined whether natto impairs infection by viruses, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as well as bovine herpesvirus 1 (BHV-1). Interestingly, our results show that both SARS-CoV-2 […]
The SAIVE Trial, Post-Exposure Use of Ivermectin in Covid-19 Prevention: Efficacy and Safety Results
Violain Desort-Henin et al. Ivermectin (IVM) is a well-known drug currently used to treat several parasitic diseases. It has a proven safety profile over many decades of exposure. It is one of the several drugs explored for its potential therapeutic and preventive role against SARS-CoV-2 infection as previous studies had reported its antiviral effects on […]
I-CARE RSV and Flu Treatment
FLCCC Alliance In adult patients, COVID-19 (Omicron variant), influenza, and RSV present with similar symptoms and physical findings. It may therefore be difficult to distinguish between these infections (particularly COVID-19 and influenza) based on clinical presentation alone. We would suggest this treatment protocol in those with diagnosed Respiratory Syncytial Virus (RSV); however, in low-risk patients […]
Past SARS-CoV-2 Infection Protection Against Re-infection: A Systematic Review and Meta-Analysis
COVId-19 Forecasting Team Understanding the level and characteristics of protection from past SARS-CoV-2 infection against subsequent re-infection, symptomatic COVID-19 disease, and severe disease is essential for predicting future potential disease burden, for designing policies that restrict travel or access to venues where there is a high risk of transmission, and for informing choices about when […]
